1. Corporate Officers - K
2. King Rachel K.

Insider Trading History of King Rachel K.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of King Rachel K. since 2019. This trader's CIK number is 1589712. At the time of last reporting, King Rachel K. was the Officer of Novavax Inc. (stock ticker symbol NVAX). Also see all insider trading activities at Novavax Inc.

Note that in the past King Rachel K. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Crescent Biopharma, Inc. (GLYC) by King Rachel K.

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2020	GLYC	0	$0	84,176	$329,128	130,821	$146,519
2019	GLYC	0	$0	0	$0	166,759	$186,770

Yearly summary of insider trading at Novavax Inc (NVAX) by King Rachel K.

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2026	NVAX	0	$0	0	$0	18,880	$0
2025	NVAX	0	$0	0	$0	10,420	$0
2024	NVAX	0	$0	0	$0	6,670	$0
2023	NVAX	0	$0	0	$0	3,100	$0
2022	NVAX	0	$0	0	$0	700	$0
2021	NVAX	700	$97,747	0	$0	6,900	$0
2019	NVAX	86,000	$45,580	0	$0	0	$0

Insider trading activities at 2 companies by King Rachel K.:

1. Crescent Biopharma, Inc. (GLYC)

2. Novavax Inc (NVAX)

Table 1. Insider trading of Crescent Biopharma, Inc. (GLYC) by King Rachel K.

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2020-12-28	GLYC	Option Ex	130,821	1.12	146,519
2020-12-28	GLYC	Sale	84,176	3.91	329,128
2019-08-06	GLYC	Option Ex	166,759	1.12	186,770

Table 2. Insider trading of Novavax Inc (NVAX) by King Rachel K.

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2026-06-20	NVAX	Option Ex	18,880	.00	0
2025-06-12	NVAX	Option Ex	10,420	.00	0
2024-06-12	NVAX	Option Ex	6,670	.00	0
2023-06-10	NVAX	Option Ex	3,100	.00	0
2022-06-17	NVAX	Option Ex	700	.00	0
2021-06-25	NVAX	Option Ex	6,900	.00	0
2021-05-19	NVAX	Buy	700	139.64	97,747
2019-03-27	NVAX	Buy	86,000	.53	45,580

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by King Rachel K. (Officer of Novavax Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month